Bank of New York Mellon’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$448K Buy
99,352
+6,878
+7% +$31K ﹤0.01% 3545
2025
Q1
$410K Buy
92,474
+25
+0% +$111 ﹤0.01% 3533
2024
Q4
$724K Buy
92,449
+894
+1% +$7K ﹤0.01% 3317
2024
Q3
$1.2M Sell
91,555
-29,399
-24% -$387K ﹤0.01% 3024
2024
Q2
$1.46M Buy
120,954
+8,974
+8% +$108K ﹤0.01% 2970
2024
Q1
$1.82M Sell
111,980
-7,987
-7% -$130K ﹤0.01% 2809
2023
Q4
$818K Buy
119,967
+362
+0.3% +$2.47K ﹤0.01% 3292
2023
Q3
$652K Buy
119,605
+1,319
+1% +$7.19K ﹤0.01% 3407
2023
Q2
$803K Buy
118,286
+5,755
+5% +$39.1K ﹤0.01% 3325
2023
Q1
$564K Sell
112,531
-809
-0.7% -$4.05K ﹤0.01% 3431
2022
Q4
$553K Sell
113,340
-15
-0% -$73 ﹤0.01% 3489
2022
Q3
$1.63M Buy
113,355
+10,698
+10% +$154K ﹤0.01% 2960
2022
Q2
$1.55M Sell
102,657
-1,478
-1% -$22.4K ﹤0.01% 2972
2022
Q1
$1.24M Buy
104,135
+790
+0.8% +$9.39K ﹤0.01% 3180
2021
Q4
$1.68M Sell
103,345
-289
-0.3% -$4.68K ﹤0.01% 3095
2021
Q3
$2.96M Buy
103,634
+12,008
+13% +$343K ﹤0.01% 2771
2021
Q2
$3.1M Sell
91,626
-9,284
-9% -$314K ﹤0.01% 2734
2021
Q1
$3.05M Sell
100,910
-6,849
-6% -$207K ﹤0.01% 2670
2020
Q4
$5.34M Buy
107,759
+2,650
+3% +$131K ﹤0.01% 2326
2020
Q3
$4.04M Buy
105,109
+506
+0.5% +$19.4K ﹤0.01% 2327
2020
Q2
$4.52M Buy
104,603
+19,140
+22% +$827K ﹤0.01% 2252
2020
Q1
$2.23M Buy
85,463
+1,631
+2% +$42.6K ﹤0.01% 2492
2019
Q4
$2.62M Buy
83,832
+24,831
+42% +$776K ﹤0.01% 2653
2019
Q3
$1.54M Buy
59,001
+1,172
+2% +$30.5K ﹤0.01% 2901
2019
Q2
$1.32M Buy
57,829
+37,609
+186% +$860K ﹤0.01% 3043
2019
Q1
$530K Buy
+20,220
New +$530K ﹤0.01% 3518